Top Institutions in Ophthalmology - Retinal Diseases
Leading academic medical centers with strong ophthalmology and retina research programs, particularly those involved in multicenter clinical trials and collaborations with the DRCR Retina Network, are recognized for their expertise in diabetic retinal disease research and treatment innovation.
-
#100
Massachusetts Eye and Ear Infirmary
Boston, MA
Home institution of the DRCR Retina Network coordinating center and a leader in diabetic retinopathy clinical trials, Massachusetts Eye and Ear has pioneered research on anti-VEGF therapies and has extensive experience in multicenter retinal disease studies.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#88
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its retinal disease research and active participation in DRCR Retina Network trials, contributing significantly to advancements in diabetic retinopathy and macular edema management.
Key Differentiators
- Ophthalmology
- Retina
- Diabetic Retinopathy Research
-
#82
University of Wisconsin-Madison, Department of Ophthalmology and Visual Sciences
Madison, WI
A key DRCR Retina Network member institution, University of Wisconsin has contributed to clinical trial design and execution, with a focus on diabetic retinal disease and anti-VEGF treatment outcomes.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#75
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is internationally recognized for its retina service and research, actively involved in DRCR Retina Network studies and advancing treatment strategies for diabetic retinal diseases.
Key Differentiators
- Ophthalmology
- Retina
- Diabetic Retinopathy
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







